[go: up one dir, main page]

AU6163398A - Identification of inhibitors of protein tyrosine kinase 2 - Google Patents

Identification of inhibitors of protein tyrosine kinase 2

Info

Publication number
AU6163398A
AU6163398A AU61633/98A AU6163398A AU6163398A AU 6163398 A AU6163398 A AU 6163398A AU 61633/98 A AU61633/98 A AU 61633/98A AU 6163398 A AU6163398 A AU 6163398A AU 6163398 A AU6163398 A AU 6163398A
Authority
AU
Australia
Prior art keywords
inhibitors
identification
tyrosine kinase
protein tyrosine
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU61633/98A
Inventor
Le T. Duong
Gideon A Rodan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of AU6163398A publication Critical patent/AU6163398A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Rheumatology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Physics & Mathematics (AREA)
  • Pain & Pain Management (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU61633/98A 1997-02-11 1998-02-09 Identification of inhibitors of protein tyrosine kinase 2 Abandoned AU6163398A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US3756097P 1997-02-11 1997-02-11
US60037560 1997-02-11
PCT/US1998/002797 WO1998035056A1 (en) 1997-02-11 1998-02-09 Identification of inhibitors of protein tyrosine kinase 2

Publications (1)

Publication Number Publication Date
AU6163398A true AU6163398A (en) 1998-08-26

Family

ID=21895000

Family Applications (1)

Application Number Title Priority Date Filing Date
AU61633/98A Abandoned AU6163398A (en) 1997-02-11 1998-02-09 Identification of inhibitors of protein tyrosine kinase 2

Country Status (5)

Country Link
EP (1) EP0968304A1 (en)
JP (1) JP2001512309A (en)
AU (1) AU6163398A (en)
CA (1) CA2277544A1 (en)
WO (1) WO1998035056A1 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6165598A (en) * 1997-02-18 1998-09-08 Lxr Biotechnology Inc. Bak promotor expression system
US6919076B1 (en) 1998-01-20 2005-07-19 Pericor Science, Inc. Conjugates of agents and transglutaminase substrate linking molecules
US6958148B1 (en) 1998-01-20 2005-10-25 Pericor Science, Inc. Linkage of agents to body tissue using microparticles and transglutaminase
AU2209899A (en) * 1998-12-30 2000-07-24 Sugen, Inc. Pyk2 (raftk) and inflammation
EP1630559A3 (en) * 1998-12-30 2006-06-07 Sugen, Inc. PYK2 (RAFTK) and inflammation
US6861442B1 (en) 1998-12-30 2005-03-01 Sugen, Inc. PYK2 and inflammation
CN1654956A (en) * 2000-05-04 2005-08-17 耶鲁大学 High density protein arrays for screening of protein activity
AU2002236692A1 (en) * 2000-10-23 2002-05-21 Bristol-Myers Squibb Company Modulators of bruton's tyrosine kinase and bruton's tyrosine kinase, their identification and use
DK1401415T3 (en) 2001-06-29 2006-10-16 Ab Science Use of N-phenyl-2-pyrimidinamine derivatives for the treatment of inflammatory diseases
JP2004537536A (en) 2001-06-29 2004-12-16 アブ サイエンス Methods of using tyrosine kinase inhibitors to treat allergic diseases
CA2452390A1 (en) * 2001-06-29 2003-01-09 Ab Science Use of tyrosine kinase inhibitors for treating bone loss
ATE343415T1 (en) 2001-06-29 2006-11-15 Ab Science THE USE OF C-KIT INHIBITORS FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASE
US7727731B2 (en) 2001-06-29 2010-06-01 Ab Science Potent, selective and non toxic c-kit inhibitors
EP1627045A2 (en) * 2003-02-28 2006-02-22 Plexxikon, Inc. Pyk2 crystal structure and uses
CA2571482A1 (en) * 2004-06-21 2005-12-29 Pharmacia & Upjohn Company Llc Pyk2 inhibitors for stimulation of osteoblast function

Also Published As

Publication number Publication date
EP0968304A1 (en) 2000-01-05
WO1998035056A1 (en) 1998-08-13
JP2001512309A (en) 2001-08-21
CA2277544A1 (en) 1998-08-13

Similar Documents

Publication Publication Date Title
AU8681798A (en) Imidazoquinoxaline protein tyrosine kinase inhibitors
AU8681698A (en) Imidazoquinoxaline protein tyrosine kinase inhibitors
AU1371999A (en) Benzothiazole protein tyrosine kinase inhibitors
EG23871A (en) Protein kinase c inhibitor
AU5324996A (en) Protein kinase c inhibitors
AU2396897A (en) 5-aminopyrazoles useful as selective inhibitors of the protein tyrosine kinase p56ick
HUS1700048I1 (en) Substituted 3-cyanoquinolines as protein tyrosine kinases inhibitors
AU6411698A (en) Substituted 2-anilinopyrimidines useful as protein kinase inhibitors
AU7289696A (en) Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors
AU7631496A (en) Substituted 2-anilinopyrimidines useful as protein kinase inhibitors
AU8760798A (en) Irreversible inhibitors of tyrosine kinases
AU3766897A (en) Fused heterocyclic compounds as protein tyrosine kinase inhibitors
AU3443997A (en) Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors
AU3693697A (en) Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors
AU8689298A (en) Tricyclic quinoxaline derivatives as protein tyrosine kinase inhibitors
PL346934A1 (en) Substituted 3-cyanoquinolines as protein tyrosine kinases inhibitors
AU3482493A (en) Novel protein tyrosine kinases
AU6163398A (en) Identification of inhibitors of protein tyrosine kinase 2
AU6882598A (en) Protein kinase inhibitor
ZA983065B (en) Inhibitors of protein farnesyltranferase
AU7687998A (en) Heteroarylcarboxamide compounds active against protein tyrosine kinase related disorders
AU2591299A (en) Human protein kinase c inhibitor
AU1456899A (en) Human protein kinase and kinase inhibitors
AU6906396A (en) Methods and compositions including dna damaging agents and tyrosine kinase inhibitors or activators
AU2310097A (en) Identification of stimuli